Claim Restrictions of Insurance Rejected: Cancer Patient Secures Justice.
Garima Singh v. New India Assurance Co. Ltd. in the Delhi High Court revolves around cancer treatment and insurance claims.
1 min read: -
Facts:
Diagnosis & Treatment:
The petitioner, Garima Singh, was diagnosed with Stage-IV breast cancer in 2021.
The cancer spread to the lymph nodes and lungs.
She underwent Chemo-immunotherapy, a combination of chemotherapy and immunotherapy.
Insurance Claim Dispute:
She held a health insurance policy covering Rs. 44.5 lakhs.
The insurance company refused to fully reimburse her treatment costs, citing a sub-limit of Rs. 2 lakhs for Monoclonal Antibody injections.
The Insurance Ombudsman ruled in her favor, directing the insurer to pay for the treatment.
But the insurance company failed to comply with the order.
Legal Arguments:
The cancer Patient had approached Hon’ble High Court for directing the Insurance company to comply with the order.
The petitioner argued that Chemo-immunotherapy is different from Monoclonal Antibody injections and should not be subjected to the Rs. 2 lakh limit.
The court applied the principle of “contra proferentem”, stating that any ambiguity in the policy should be interpreted in favor of the insured.
The court held that Chemo-immunotherapy is a modern treatment and should not be restricted by the sub-limit.
Final Verdict:
The court ordered the insurance company to pay the full amount claimed by the petitioner.
The court also imposed a fine of Rs. 50,000 on the insurance company for causing mental agony and harassment to the petitioner.
Comments
Post a Comment